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154Objective: Primary graft dysfunction, a severe form of lung injury that occurs in the first 72 hours after lung trans-
plant, is associated with morbidity and mortality. We sought to assess the impact of an evidence-based guideline
as a protocol for respiratory and hemodynamic management.
Methods: Preoperative and postoperative data for patients treated per the guideline (n¼ 56) were compared with
those of a historical control group (n ¼ 53). Patient data such as ratio of arterial PO2 to inspired oxygen fraction,
central venous pressure, cumulative fluid balance, vasopressor dose, and serum urea and creatinine were mea-
sured and documented at specific times. Primary outcome was severity of primary graft dysfunction within the
first 72 hours.
Results: Primary graft dysfunction grade was progressively lower in patients treated after introduction of the
guideline (P ¼ .01). Lower postoperative fluid balances (P ¼ .01) and vasopressor doses (P ¼ .007) were
seen, with no associated renal dysfunction. There were no differences in duration of mechanical ventilation or
mortality. Nonadherence to the guideline occurred in 10 cases (18%).
Conclusions: Implementation of an evidence-based guideline for managing respiratory and hemodynamic status
is feasible and safe and was associated with reduction in severity of primary graft dysfunction. Further studies are
required to determine whether such a guideline would lead to a consistent reduction in severity of primary graft
dysfunction at other institutions. Creation of a protocol for postoperative care provides a template for further stud-
ies of novel therapies or management strategies for primary graft dysfunction. (J Thorac Cardiovasc Surg
2010;139:154-61)With some similarities to the adult respiratory distress syn-
drome in nontransplant settings, primary graft dysfunction
(PGD) is a severe form of acute lung injury that develops
in the first 72 hours after lung transplant and is associated
with significant early and late morbidity and mortality.1,2
Published consensus criteria for defining and classifying
the severity of PGD according to the ratio of recipient arte-
rial PO2 (PO2) to fraction of inspired oxygen (FiO2) and chest
radiographic findings (Table 1)3 offer the opportunity for
uniform identification of PGD. Further refinements recently
advocated by Oto and colleagues4 may further enhance the
reliability and grading of current PGD criteria and assist in
earlier identification and management of PGD in the inten-
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The Journal of Thoracic and Cardiovascular SurgAfter noting that lung protective strategies with low tidal
volume ventilation improve outcomes in patients with adult
respiratory distress syndrome,5 we postulated that a similar
approach might be beneficial for severe PGD. Indeed, it
has been recommended that protective mechanical ventila-
tion strategies should be instituted in the postoperative man-
agement of patients with PGD.6 In addition, because central
venous pressure (CVP) greater than 7 mm Hg has been
shown to correlate positively with increased duration of me-
chanical ventilation and mortality after lung transplant,7 it
seemed apparent that therapy aimed at maintaining the
CVP at or below 7 mm Hg (such as fluid restriction) might
improve outcomes. On the basis of these principles, a guide-
line for the postoperative hemodynamic and respiratory
management of all lung transplant recipients was developed.
Our hypothesis was that the implementation of such a guide-
line might be associated with improved outcomes. We
sought to assess the guideline’s effect by prospectively
studying patients managed after the implementation of the
guideline and comparing their outcomes with those of a co-
hort of historical control patients. The purpose of this article
is to report changes in outcomes that occurred after the
guideline’s implementation.
MATERIALS AND METHODS
Guideline Development and Implementation
The guideline was developed during early 2005 and introduced into clin-
ical practice in October 2005. Its implementation was supported withery c January 2010
TABLE 1. Criteria for grading severity of primary graft dysfunction3
Currey et al Cardiothoracic TransplantationGrade CriteriaAbbreviations and Acronyms0 PaO2/FiO2>300 with no pulmonary infiltrates on chestCVP ¼ central venous pressure
radiographyFiO2 ¼ fraction of inspired oxygenExtubated with FiO2<30% or nasal cannulasICU ¼ intensive care unit
Extubated with no pulmonary infiltrate on chest radiography,PaO2 ¼ arterial PO2irrespective of PaO2/FiO2PGD ¼ primary graft dysfunction
1 PaO2/FiO2>300 with pulmonary infiltrates on chest radiography
2 PaO2/FiO2 200–300
3 PaO2/FiO2<200
Requirement for mechanical ventilation, nitric oxide, and FiO2
>50% beyond 48 h
Requirement for extracorporeal membrane oxygenation
PaO2, Arterial PO2; FiO2, inspired oxygen fraction.
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Xmedical and nursing education in the form of lectures and bedside advice.
The 56 patients with lung transplants (42 double and 14 single transplants)
managed after the introduction of the guideline until the planned completion
of the study in January 2007 comprised the intervention group. One patient
was excluded from the study because of admission to the ICUwith extracor-
poreal membrane oxygenation. The historical control group consisted of all
patients receiving lung transplants between March 2004 and September
2005, comprising 53 patients (43 double and 10 single transplants). Stan-
dardization of lung recovery techniques with antegrade and retrograde pres-
ervation with Perfadex (Vitrolife, Go¨teborg, Sweden) was introduced in
March 2004 for all patients. Transplant techniques followed standard surgi-
cal practice.8-10 The study was approved by the human research and ethics
committees of The Alfred Hospital and Deakin University.
The guideline is shown in Figures 1 and 2. Clinicians were directed to
measure the PaO2/FiO2 ratio and cardiovascular parameters at specific times
after admission to the ICU (0, 3, 6, 12, 24, 48, and 72 hours) and more fre-
quently if clinically indicated. Respiratory management was then stratified
according to the PaO2/FiO2 ratio, with the aim of providing protective ven-
tilation or weaning the patient from mechanical ventilation as appropriate.
Cardiovascular management was aimed at maintaining adequate cardiac in-
dex and blood pressure, with a CVP 7 mm Hg or lower if possible. When
PaO2/FiO2 ratio was greater than 300 and both cardiac index and blood pres-
sure were adequate, the goal of maintaining a low CVP was no longer pur-
sued aggressively. The guideline not only served as a protocol care of the
more stable patients but also specified thresholds at which nursing staff
and junior medical staff should seek more senior help.
Other Aspects of Management
Other aspects of management remained unchanged, included donor as-
sessment, recipient selection, donor–recipient matching, and postoperative
medical management. The Alfred Hospital’s approach to lung donor refer-
ral, assessment, and general management has been described elsewhere.9
Recipient selection is based on international guidelines.11 Donor–recipient
matching was generally undertaken according to our standard protocol,
which has also been described previously.8 Prospective donor–recipient
T- and B-cell lymphocytotoxic crossmatching was performed in all cases.
There were no changes in assessment or selection criteria during the study
period. Postoperative triple immunosuppression was achieved and acute re-
jection was diagnosed and treated according to standard protocols and prac-
tice.8,9,12 All patients received prophylactic antibiotics on the basis of
known or suspected donor and recipient microbiologic results. Ganciclovir
was used as prophylaxis against cytomegalovirus as indicated. Immunosup-
pressive regimens and antibiotic and antiviral prophylaxis regimens did not
change during the study period. None of the medical or surgical manage-
ment practices were consciously altered during the period examined.
Outcomes
The severity of PGD (stratified into 3 groups of grades 0 and 1, grade 2,
and grade 3) within the first 72 hours was the primary outcome. Patients
were assigned PGD grades according to the consensus guidelines issued
by the International Society for Heart & Lung Transplantation Working
Group.3 We did not analyze chest radiographs for the presence or absence
of infiltrates when defining grades of PGD, because we previously notedThe Journal of Thoracic and Cathat this practice does not significantly affect the grading proportions.4
PGD grades 0 and 1 (PaO2/FiO2 ratio>300) were analyzed as a single group.
Secondary outcomes included duration of mechanical ventilation, ICU stay,
use of inhaled nitric oxide, vasopressor (norepinephrine) dose, fluid balance
during the first 72 hours, renal function (urea and creatinine on postopera-
tive days 3 and 7), in-ICUmortality, in-hospital mortality, and ICU readmis-
sion rates. Nonadherence to the guideline was assessed according to 3
predefined criteria (lack of documentation of PaO2/FiO2 ratio, deviation
from the guideline without documented clinical indication, or no guideline
at the bedside).
Statistical Analysis
Data were analyzed with SAS version 9.1 software (SAS Institute Inc,
Cary, NC). Analysis of the 2 groups was on an intention-to-treat basis.
All outcomes were assessed for normality and log transformed where appro-
priate. Univariate comparisons were performed with c2 tests for equal pro-
portion, Student t tests for normally distributed outcomes, and Wilcoxon
rank sum tests otherwise. Comparison of time to extubation was performed
with a log-rank test, with results presented as Kaplan–Meier curves. Para-
metric data are presented as mean  SD. Nonparametric data are expressed
as median and interquartile range. Longitudinal analysis of continuously
normally distributed outcomes (fluid balance and log of norepinephrine)
were performed with mixed modeling (MIXED procedure), whereas longi-
tudinal analysis of PGD grade was performed with ordinal mixed modeling
(NL MIXED procedure). Longitudinal ordinal regression models for PGD
were constructed with both a random intercept model and a random trend
model. All mixed models were constructed with main effects for group
and time and an interaction between group and time. Because group alloca-
tion was not randomly assigned, a propensity score for the intervention
group was constructed to account for baseline imbalances and potential al-
location bias, in accordance with Rubin,13 and was then included as a cova-
riate in the longitudinal analyses. The propensity model was constructed by
means of logistic regression with the following baseline variables fitted as
predictors: recipient age, recipient sex, recipient smoking history, classifica-
tion of recipient disease (obstructive, restrictive, or vascular), transplant
type (double or single), duration of surgery, donor PaO2, ischemic time,
baseline CVP on admission to ICU, and baseline PGD grade on admission
to ICU. Longitudinal results have been presented as means for fluid balance
and geometric means for norepinephrine. For ease of interpretation, PGD
grades have also been presented as the mean PGD grade at each time point.
Analyses were independent of the funding agency.
The baseline characteristics (donor, recipient, operative, and immediate
postoperative factors on arrival in ICU) of the 2 groups are shown in Table
2. There was a greater proportion of patients with restrictive lung disease
and a lower proportion of patients with obstructive lung disease in therdiovascular Surgery c Volume 139, Number 1 155
FIGURE 1. Lung transplant guideline, page 1. Respiratory management during intubation. ICU, Intensive care unit; PaO2, arterial PaO2; FiO2, fraction of
inspired oxygen;MAP,mean arterial pressure; PTO, please turn over; SIMV, synchronized intermittent mandatory ventilation; PEEP, positive end-expiratory
pressure; ET, endotracheal; ICC, intercostal catheter; tx, transplant.
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Xpostguideline group. On arrival in ICU from the operating room, a higher
proportion of the postguideline group had CVPs greater than 7 mm Hg (Ta-
ble 2). Otherwise, there were no differences between the 2 groups in donor
characteristics and no differences in the preoperative, operative, and initial
ICU characteristics of the recipients.RESULTS
Primary Outcome
The primary outcome was severity of PGD within the first
72 hours. Longitudinal ordinal regression models for PGD156 The Journal of Thoracic and Cardiovascular Surg(constructed with both a random intercept model and a ran-
dom trend model) confirmed a significant interaction be-
tween group and time (P ¼ .01 and P ¼ .02, respectively).
This indicated that during the course of the 72 hours the 2
groups behaved differently, with the postguideline group
tending toward a lower PGD grade (Figure 3).
Secondary Outcomes
There was a statistically significant group effect for cumu-
lative fluid balance, with the postguideline groupery c January 2010
FIGURE 2. Lung transplant guideline, page 2. Hemodynamic management in first 72 hours. MAP, Mean arterial pressure; CVP, central venous pressure;
PaO2, arterial PaO2; FiO2, fraction of inspired oxygen;NSA, normal serum albumin; ICC, intercostal catheter; RR, respiratory rate; Vt, tidal volume;CXR, chest
radiograph; TOE, transesophageal echocardiography.
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Xconsistently lower during the 72-hour period (P ¼ .01).
There was also a significant interaction between group and
time (P ¼ .001), indicating that the difference in cumulative
fluid balance between groups became larger as time pro-
gressed (Figure 4). Despite the lower cumulative fluid bal-
ances, norepinephrine dose requirements (Figure 5) were
significantly lower in the postguideline group during the
72-hour period (P ¼ .007), although there was no evidence
to suggest that the 2 groups behaved differently with time
(interaction P¼ .70). There were no other differences in sec-
ondary outcomes (Table 3). Kaplan Meier analysis did not
demonstrate any difference in the duration of mechanical
ventilation between patients managed by the guideline and
the preguideline group (Figure 6). Nonadherence to the
guideline (as defined in advance by specific criteria) by the
ICU staff was observed in 10 of 56 cases.
DISCUSSION
Our study demonstrated that care of lung transplant recip-
ients according to a protocol is possible. The implementation
of an evidence-based guideline was associated with a reduc-
tion in the severity of PGD within the first 72 hours afterThe Journal of Thoracic and Calung transplant. After the introduction of the guideline, there
was less administration of intravenous fluid. This was not as-
sociated with any deterioration in renal function or increased
requirement for vasopressor agents (indeed, norepinephrine
requirements were lower in the postintervention group).
Our guideline provided the means to identify and manage
PGD in the early postoperative period in an attempt to re-
duce the severity of PGD. Although the introduction of the
guideline was associated with a reduction in severity of
PGD, it is not clear whether this was a direct consequence
of the guideline or whether other factors were more impor-
tant in determining the severity of PGD. The occurrence of
PGD has been shown to affect early outcomes and long-
term survival after transplant.14 Further, more severe PGD
on admission to ICU has been associated with an increased
risk of bronchiolitis obliterans syndrome.15 The findings of
these studies suggest that any intervention leading to reduc-
tion in the severity of PGD in the early postoperative period
might, if applied widely enough, have important long-term
clinical implications.
Although PGD is defined by the presence of a reduced
PaO2/FiO2 ratio in the first 72 hours after transplant,
3 it isrdiovascular Surgery c Volume 139, Number 1 157
TABLE 2. Baseline characteristics
Characteristic
Before
guidelines
(n ¼ 53)
After
guidelines
(n ¼ 56)
P
value
Recipient factors
Age (y, mean  SD) 46.6  14.1 47.3  14.5 .799
Female (%) 43% (23/53) 54% (30/56) .256
Body mass
index (kg/m2, mean  SD)
22.3  4.0 22.3  4.2 .985
Vascular lung
disease (%)
5.7% (3/53) 5.5% (3/56) >.999
Obstructive lung
disease (%)
84.9% (45/53) 63.6% (35/56) .015
Restrictive lung
disease (%)
9.4% (5/53) 30.9% (17/56) .008
Donor factors
Age (y, mean  SD) 37.0  13.2 39.5  15.7 .374
Arterial PO2 (mm Hg, mean
 SD)
446.4  110.4 436.8  93.2 .640
Female (%) 39.6% (21/53) 46.4% (26/56) .563
History of smoking (%) 52.8% (28/53) 55.4% (31/56) .847
Inotropes (%) 83.0% (44/53) 83.9% (47/56) .100
Operative factors
Ischemic time
(min, mean  SD)
359  20 338  18 .440
Duration of surgery
(hours, mean  SD)
6.0  1.5 5.9  1.9 .634
Double-lung transplant (%) 81.1% (43/53) 76.4% (42/56) .641
Initial findings on arrival in intensive care unit
Primary graft
dysfunction grade 2 or 3 (%)
56% (28/50) 43% (24/56) .180
Central venous pressure
(mm Hg, median and IQR)
4.5 (5–10) 7 (2–6) .001
Central venous
pressure>7 mm Hg (%)
20% (9/45) 50% (28/56) .002
Mean arterial pressure
(mm Hg, mean  SD)
68.9  13.5 72.9  9.9 .322
Cardiac index (L/[min $ m2],
mean  SD)
3.1  1.2 3.0  1.2 .623
Norepinephrine
(m/min, median and IQR)
4 (2–6) 3.75 (2–6) .731
Urea (mmoL, mean  SD) 5.8  2.3 6.3  2.6 .283
Creatinine (mmoL, mean 
SD)
81  26 77  32 .496
IQR, Interquartile range.
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Xunknown whether there are time points within this period
that are more clinically relevant. Oto and coworkers16 sug-
gested that the PaO2/FiO2 ratio as early as 6 or 12 hours after
transplant predicts length of ventilation and stay in ICU. Pre-
kker and colleagues17 have suggested that the grade of PGD
at 48 hours provides the clearest differentiation of 90-day
mortality. Although the severity of PGD during the first 72
hours after lung transplant was indeed different after the in-
troduction of the guideline, mortalities were identical in the
groups (Table 3). Mortalities associated with lung transplant158 The Journal of Thoracic and Cardiovascular Surgat The Alfred Hospital (2004–2006) were 3.5% at 3 months
and 7% at 1 year, which compare favorably with respective
figures of 7.8% and 15.9% reported for the year 2004 from
the United Network for Organ Sharing database.18 It may be
that other factors are responsible for the low mortality at our
institution and that these factors were not controlled for in
our trial and are completely unrelated to the guideline. It is
possible, however, that a guideline such as ours may provide
a template to standardize postoperative care and thus study
therapeutic interventions targeted to reduce the incidence
of PGD, which might translate into more clinically relevant
outcomes such as duration of ventilation, stay in ICU, and
ultimately mortality.
For an evidence-based guideline to be effective in chang-
ing the process and improving the outcomes of care, multi-
disciplinary team members should be involved in the
development, implementation, and ongoing updating of
the guideline.19,20 Our guideline adhered to these principles
and was based on the best available evidence at the time. It
will continue to be reviewed and modified to incorporate
new evidence as needed.21 Indeed, it was noted on a few oc-
casions that although respiratory and hemodynamic param-
eters were acceptable to allow discontinuation of mechanical
ventilation, extubation was delayed because of inadequate
analgesia. The next revised version will include a pain man-
agement strategy.
Adherence to the guideline was acceptable, and its imple-
mentation was well received by both medical and nursing
staff. The preguideline and postguideline groups were well
matched in most areas. The postguideline group did have
higher CVPs on admission to ICU and a higher proportion
of patients with restrictive lung disease. These 2 factors
might be considered to represent increased risks for difficult
postoperative course and higher likelihood of PGD3,4,7; in
fact, however, the opposite was seen.
There are a number of limitations of our study. First, this
was not a randomized, controlled trial, and it is possible that
factors not accounted for in this study may have led to the
changes observed between the preguideline and postguide-
line groups. Management of these patients may have im-
proved during the duration of the study as a result of the
subtly progressive acquisition of knowledge and skills by
clinicians. Indeed, despite the effort taken to ensure that all
relevant information was included, recorded, and analyzed,
it is possible that incomplete analysis of retrospective data
may have biased our results. Second, it is possible that the
trend toward a higher incidence of PGD on arrival in ICU
seen in the historical cohort was indeed a reflection that
the group was more likely to have PGD at other time points
after transplant, although we attempted to adjust for this pos-
sibility in our analysis. Third, although creation of a protocol
for respiratory management to introduce small tidal volumes
and to seek senior help for patients with the worst oxygena-
tion parameters is likely to have helped minimize lungery c January 2010
FIGURE 3. Mean primary graft dysfunction (PGD) grade after admission to intensive care unit (ICU) in preguideline and postguideline groups. Mean pri-
mary graft dysfunction grade (with SEs indicated by error bars) at time points after admission to intensive care unit for preguideline and postguideline groups.
Longitudinal ordinal regression models for primary graft dysfunction (constructed with both random intercept model and random trend model) confirmed
significant interaction between group and time (P ¼ .01 and P ¼ .02, respectively).
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Xinjury, it is possible that some patients still received injuri-
ous ventilation with high airway pressures. Fourth, it is pos-
sible that the lower use of vasopressors and less positive
fluid balance were consequences of more aggressive fluid re-
suscitation in the operating room. This possibility is sup-FIGURE 4. Mean cumulative fluid balance to 72 hours from intensive care un
error bars) at time points after admission to intensive care unit for preguideline
significant group effect, with postguideline group consistently lower during 72-h
and time (P ¼ .001), indicating that difference in cumulative fluid balance betw
The Journal of Thoracic and Caported by the finding that this group had higher CVPs on
admission to ICU. Fifth, it is important to consider that
this study involved more than just the implementation of
a simple flowchart by the bedside. It is possible that any
changes in outcome were equally due to the education andit (ICU) admission. Mean cumulative fluid balance (with SEs indicated by
and postguideline groups. Longitudinal analysis demonstrated statistically
our period (P ¼ .01). There was also significant interaction between group
een groups became larger as time progressed.
rdiovascular Surgery c Volume 139, Number 1 159
T
FIGURE 5. Norepinephrine (Noradrenaline) dose after admission to intensive care unit (ICU) in preguideline and postguideline groups. Norepinephrine
dose (geometric mean with SEs indicated by error bars) at time points after admission to intensive care unit for preguideline and postguideline groups. Lon-
gitudinal analysis indicated norepinephrine dose requirements were significantly lower in postguideline group during 72-hour period (P¼ .007). There was no
evidence to suggest that groups behaved differently with time (interaction P ¼ .70).
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Xsupport provided to clinicians by the transplant and research
team. Sixth, it unknown whether wider application of guide-
lines such as ours might translate into changes in clinically
important outcomes, such as duration of ventilation, stay,
and mortality, for larger groups of patients.CONCLUSIONS
In this preinterventional and postinterventional study, we
investigated the impact of implementing an evidence-based
guideline to manage transplant recipients’ hemodynamic
and respiratory statuses in the first 72 hours, with the aim
of minimizing the severity of PGD. Postoperative care of
lung transplant patients according to a protocol was possi-
ble, did not appear to be associated with adverse effectsTABLE 3. Secondary outcomes
Outcome Before guide
Duration of mechanical ventilation (h, median and
IQR)
22 (
ICU stay (d, median and IQR) 3.1 (
Inhaled nitric oxide (%) 24.5% (
Readmission to ICU (%) 9.4% (
Death in ICU (%) 1.9% (
Death in hospital (%) 1.9% (
Urea at 72 h (mmoL, mean  SD) 9.6 
Urea at 1 wk (mmoL, mean  SD) 8.8 
Creatinine at 72 h (mmoL, mean  SD) 81 
Creatinine at 1 wk (mmoL, mean  SD) 69 
IQR, Interquartile range; ICU, intensive care unit.
160 The Journal of Thoracic and Cardiovascular Surg(renal function was unchanged; fluid and vasopressor
administration were lower), and was associated with
a reduction in severity of PGD. Although there was no
reduction in duration of mechanical ventilation or mortality,
our results suggest that further studies of protocol-based
care in larger samples are warranted. When combined
with the recently refined PGD grading system,3,4 these
guidelines provide a practical tool that allows safe standard-
ization of post-operative lung transplant management. In
turn, this may facilitate multicenter studies aimed at assess-
ing novel strategies aimed at minimizing the significant
adverse effects of PGD.
We thank the clinical staff of the Alfred Hospital intensive care
unit for supporting this research.lines (n ¼ 53) After guidelines (n ¼ 56) P value
9–54) 20 (13–45) .821
1.9–7.1) 3.6 (2.1–5.0) .912
13/53) 16.1% (9/56) .342
5/53) 10.7% (6/56) >.999
1/53) 1.9% (1/56) >.999
1/53) 1.9% (1/56) >.999
5.4 9.5  5.8 .913
6.3 8.5  4.6 .239
38 73  29 .781
26 67  19 .630
ery c January 2010
Kaplan Meier analysis of time to extubation post transplant
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FIGURE 6. Kaplan–Meier analysis of time to extubation after transplant.
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